Q1 FY2027 · ended Jun 30, 2026 · Revenue $41.02M, -19.9% YoY · Filed Aug 13, 2026
PetMed Express, Inc. (PETS) files with the SEC under industry code 5912, Retail-Drug Stores and Proprietary Stores. In Q1 of fiscal 2027, the quarter ended Jun 30, 2026, it reported revenue of $41.0 million and a net loss of $6.1 million. Free cash flow was -$8.3 million. As of Jun 30, 2026 it held $13.1 million in cash and investments and $414,000 in total debt.
Revenue
$41.02M
-19.9% vs year-ago quarter
Net income
$-6.14M
+82.0% vs year-ago quarter
Operating cash flow
$-7.69M
+37.4% vs year-ago quarter
Free cash flow
$-8.33M
+38.6% vs year-ago quarter
EPS
$-0.28
+83.0% vs year-ago quarter
Dividend per share
$0.00
Shares outstanding
21.68M
+1.5% vs prior quarter
Net cash
$12.66M
Q1 FY2027
Operating margin
-18.2%
TTM
Company profile
- Industry
- Retail-Drug Stores and Proprietary Stores (SIC 5912)
- Listed as
- PETS (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- FL
- Headquarters
- Delray Beach, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1040130
Other Retail-Drug Stores and Proprietary Stores companies
- CVS HEALTH Corp CVS
- Guardian Pharmacy Services, Inc. GRDN
- 111, Inc. YI
- Ridgetech Inc. RDGT
- TREES Corp (Colorado) CANN
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q1 FY2027 Jun 30, 2026 |
Q4 FY2026 Mar 31, 2026 |
Q3 FY2026 Dec 31, 2025 |
Q2 FY2026 Sep 30, 2025 |
Q1 FY2026 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $41.0M | $42.8M | $40.7M | $44.4M | $51.2M |
| Operating income | -$6.2M | -$5.7M | -$10.5M | -$8.4M | -$34.1M |
| Net income | -$6.1M | -$4.1M | -$10.6M | -$8.5M | -$34.2M |
| Diluted EPS | -$0.28 | -$0.19 | -$0.50 | -$0.41 | -$1.65 |
| Operating cash flow | -$7.7M | -$4.7M | -$9.2M | -$2.2M | -$12.3M |
| Free cash flow | -$8.3M | -$5.5M | -$9.2M | -$4.8M | -$13.6M |
| Total assets | $63.8M | $81.2M | $88.0M | $100.3M | $109.8M |
| Total liabilities | $40.8M | $52.3M | $55.2M | $57.2M | $58.3M |
| Stockholders' equity | $23.0M | $28.9M | $32.8M | $43.1M | $51.5M |
| Cash and investments | $13.1M | $21.4M | $26.9M | $36.1M | $41.1M |
| Total debt | $414,000 | $534,000 | $652,000 | $768,000 | $883,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Sep 28, 2026 | Sep 27, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 21, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 17, 2026 | Sep 17, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 12, 2026 | Aug 11, 2026 |
All 1001 PetMed Express, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.